Liquid Biospy for Urinary Cancers
The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.
| Condition(s) | Urothelial Carcinoma |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs. |
| Who can participate | Inclusion Criteria: Diagnosis of urothelial neoplasia, naive for therapy Exclusion Criteria: Absence of previous neolpastic disease or genetic diseases |
| Ages | 40 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | IRCCS San Raffaele |
| Locations | Milan, Italy |
| Start date | 2020-09-29 |
| NCT ID | NCT06116396 |
| Official listing | https://clinicaltrials.gov/study/NCT06116396 |